Subscribe to RSS

DOI: 10.1055/s-0044-1795072
Perspective on the Influence of Biopsy on the Survival of Pediatric Patients with Diffuse Brainstem Gliomas: A Literature Review
Perspectiva da influência da biópsia na sobrevida de pacientes pediátricos com Gliomas Difusos do Tronco: Uma revisão de literatura
Abstract
Introduction Diffuse brainstem gliomas (DBG) represent the most common subtype of pediatric brainstem tumors, characterized by a systematically grim prognosis with a median survival rate of 10% two years post-diagnosis. Unlike other brain tumors, diffuse brainstem gliomas have traditionally relied on cranial magnetic resonance imaging (MRI) as a sufficient diagnostic tool, rendering surgical biopsies deemed unnecessary.
Objectives To conduct a literature review aiming to assess whether the performance of surgical biopsies has influenced the survival outcomes of children with diffuse brainstem gliomas.
Materials and Methods A comprehensive literature review was conducted using electronic databases PubMed, Embase, and LILACS. The search terms included “glioma” or “diffuse glioma” in conjunction with “pediatric” or “childhood,” combined with “biopsy” or “stereotactic,” and further combined with “brainstem,” “pons,” “pontine,” or “mesencephalon,” along with “survival.” The searches were limited to studies involving pediatric patients (age <18 years) published between 1980 and 2021.
Results The analysis of the presented data revealed morbidity ranging from 0% to 33.3% and mortality from 0% to 2.2%. Transfrontal access was predominantly favored by most authors, followed by transcerebellar approaches. The rate of inconclusive biopsies varied from 0% to 30%.
Conclusion Given the infiltrative nature of diffuse brainstem gliomas; surgical resection is generally deemed impractical. Radiation therapy remains the standard treatment, providing a marginal survival benefit of ∼3 months. There is currently no established chemotherapy protocol for this pathology.
Resumo
Introdução Gliomas difusos do tronco (GDT) são o subtipo de tumor de tronco pediátrico mais comum, com prognóstico sistematicamente sombrio e sobrevida média de 10%, após 2 anos do diagnóstico. Diferentemente dos outros tumores cerebrais, a ressonância magnética de crânio é considerada suficiente para diagnóstico dos gliomas de tronco, fazendo com que a biópsia seja desnecessária.
Objetivos Realizar uma revisão de literatura buscando verificar se a realização de biópsias cirúrgicas impactou de alguma forma na sobrevida das crianças com GDT.
Materiais e Métodos Revisão bibliográfica nas bases de pesquisa de dados eletrônicos PubMed, Embase e LILACS; a partir dos termos: “glioma” ou “glioma difuso,” em associação com “pediátrico” ou infância,” em combinação com “biópsia” ou “estereotática,” em combinação com “tronco cerebral,” ou “ponte,” ou “pontino,” ou “mesencéfalo” em combinação com “sobrevida.” As pesquisas foram limitadas a estudos em pacientes pediátricos (idade <18 anos), publicados entre 1980 2021.
Resultados Através da análise dos dados expostos foi possível observar que a morbidade variou de 0 a 33,3% e a mortalidade de 0 a 2,2%. A maioria dos autores preferiu a via de acesso transfrontal, seguida pela transcerebelar. A taxa de biópsias inconclusivas variou de 0 a 30%.
Conclusão Devido às características infiltrativas do tumor, a ressecção cirúrgica é desconsiderada. A radioterapia continua sendo o padrão de tratamento, conferindo benefício de sobrevida de cerca de 3 meses. Não há padrão de quimioterapia definido para essa patologia.
Palavras-chaves
neoplasias do tronco encefálico - gliomas - linha média - difusos - infância - biópsiaPublication History
Received: 02 February 2024
Accepted: 18 October 2024
Article published online:
18 November 2024
© 2024. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI. Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 2017; 20 (03) 261-268
- 2 Kickingereder P, Willeit P, Simon T, Ruge MI. Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 2013; 72 (06) 873-881 , discussion 882, quiz 882
- 3 Robison NJ, Kieran MW. Diffuse intrinsic pontine glioma: a reassessment. J Neurooncol 2014; 119 (01) 7-15
- 4 David N. . Louis, Hiroko Ohgaki, Otmar D. Wiestier, et al. WHO Classification od Tumours Classification of brain tumours of the Central Nervous System 4th ed. France: International Agency for Research on Cancer,; 2016
- 5 Mohammad F, Weissmann S, Leblanc B. et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med 2017; 23 (04) 483-492
- 6 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
- 7 Hankinson TC, Campagna EJ, Foreman NK, Handler MH. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. J Neurosurg Pediatr 2011; 8 (01) 97-102
- 8 Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP. Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 1986; 65 (06) 745-750
- 9 Epstein F. Intrinsic Brain Stem Tumors of Childhood. In: Kageyama N, Takakura K, Epstein FJ, Hoffman HJ, Schut L. organizadores. Progress in Tumor Research [Internet]. S. Karger AG; 1987. [citado 18 de outubro de 2021]. p. 160–9. Available at: https://www.karger.com/Article/FullText/413673
- 10 Albright AL, Price RA, Guthkelch AN. Brain stem gliomas of children. A clinicopathological study. Cancer 1983; 52 (12) 2313-2319
- 11 Samadani U, Judy KD. Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereotact Funct Neurosurg 2003; 81 (1-4): 5-9
- 12 Cage TA, Samagh SP, Mueller S. et al. Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Childs Nerv Syst 2013; 29 (08) 1313-1319
- 13 Chen LH, Pan C, Diplas BH. et al. The integrated genomic and epigenomic landscape of brainstem glioma. Nat Commun 2020; 11 (01) 3077
- 14 Balakrishnan I, Danis E, Pierce A. et al. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep 2020; 33 (03) 108286
- 15 Grasso CS, Tang Y, Truffaux N. et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 2015; 21 (06) 555-559
- 16 Park J, Lee W, Yun S. et al. STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma. Oncol Lett 2020; 20 (02) 1989-1998
- 17 Ogiwara H, Morota N. The efficacy of a biopsy of intrinsic brainstem lesions for decision making of the treatments. Childs Nerv Syst 2013; 29 (05) 833-837
- 18 Morais BA, Solla DJF, Matushita H, Teixeira MJ, Monaco BA. Pediatric intrinsic brainstem lesions: clinical, imaging, histological characterization, and predictors of survival. Childs Nerv Syst 2020; 36 (05) 933-939
- 19 Dellaretti M, Touzet G, Reyns N. et al. Correlation among magnetic resonance imaging findings, prognostic factors for survival, and histological diagnosis of intrinsic brainstem lesions in children. J Neurosurg Pediatr 2011; 8 (06) 539-543
- 20 Quick-Weller J, Tichy J, Dinc N. et al. Benefit and complications of frame-based stereotactic biopsy in old and very old patients. World Neurosurg 2017; 102: 442-448
- 21 Manoj N, Arivazhagan A, Bhat DI. et al. Stereotactic biopsy of brainstem lesions: Techniques, efficacy, safety, and disease variation between adults and children: A single institutional series and review. J Neurosci Rural Pract 2014; 5 (01) 32-39
- 22 Pérez-Gómez JL, Rodríguez-Alvarez CA, Marhx-Bracho A, Rueda-Franco F. Stereotactic biopsy for brainstem tumors in pediatric patients. Childs Nerv Syst 2010; 26 (01) 29-34
- 23 Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A. Brainstem stereotactic biopsy sampling in children. J Neurosurg 2006; 104 (02) 108-114
- 24 Wang ZJ, Rao L, Bhambhani K. et al. Diffuse intrinsic pontine glioma biopsy: a single institution experience. Pediatr Blood Cancer 2015; 62 (01) 163-165